“…With the development of nanotechnology, in the treatment of tumor diseases, drugs conjugated or adsorbed onto nanocarriers have shown many advantages compared with free drugs, such as controlled drug release, altered drug biodistribution, prolonged drug circulation in the blood, and anti-multidrug resistance; these systems have become an interesting research topic. 9,10 Since PEG has advantageous biological properties, including high biocompatibility and the weak interactions between PEG and proteins, cells and immunogenic, it has been used extensively for coupling with biological molecules, such as proteins, enzymes, oligonucleotides, and growth factors. When linked to a therapeutic drug, this ligand can be exploited to carry the nonselective drug specically into the cancer cells.…”